Effectiveness of biologics for endoscopic healing in patients with isolated proximal small bowel Crohn’s disease

doi:10.3748/wjg.v31.i7.98448

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1355)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-2) series.

Item

Count

PDF

HTML

653

Figures (1-5)

128

Tables (1-2)

106

Sum=928

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

195

Sum=274

Publishing Process of This Article

Item

Count

Browse

Download

Sum=76

Feb 21, 2025 (publication date) through Apr 3, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Feb 21, 2025; 31(7): 98448
Published online Feb 21, 2025. doi: 10.3748/wjg.v31.i7.98448

Full Size Figure Download Figure

Figure 2 The flow of enrolled patients in this study. Active endoscopic disease was defined as having a modified simple endoscopic score for Crohn’s disease ≥ 3, accompanied by any size ulcer. BAE: Balloon-assisted enteroscopy; SB: Small bowel; CD: Crohn’s disease; SES-CD: Simple endoscopic score for Crohn’s disease.

Citation: Huang ZC, Wang BY, Peng B, Liu ZC, Lin HX, Yang QF, Tang J, Chao K, Li M, Gao X, Guo Q. Effectiveness of biologics for endoscopic healing in patients with isolated proximal small bowel Crohn’s disease. World J Gastroenterol 2025; 31(7): 98448
URL: https://www.wjgnet.com/1007-9327/full/v31/i7/98448.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i7.98448